Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Posts Rise in Q2 Revenues; Initiates Stock Buyback Plan

NEW YORK, July 27 (GenomeWeb News) - Third Wave Technologies today reported an increase in its second-quarter revenues, accompanied by narrowed losses and a rise in R&D spending. Additionally, the company announced that its board of directors has approved a stock repurchase plan for up to 5 percent of the company's 40.4 million outstanding shares.

 

At the stock's current value, the buyback plan could be worth as much as $6.7 million.

 

Third Wave reported total revenues of $12.6 million for the quarter ended June 30, 2004 -- a 40 percent increase over total revenues of $8.8 million for the same period of 2003. The company also recorded deferred revenue of $5.1 million related to a product shipment that is "subject to acceptance" by a "key" customer.

 

The company posted a net loss of $106,000, or $.00 per diluted share, for the second quarter, compared to a net loss of $2.2 million, or $.05 per diluted share, for the year-ago period.

 

Third Wave spent $3.4 million on R&D during the quarter, up from $2.9 million in R&D spending for the second quarter of 2003.

 

The company's cash, cash equivalents, and short-term investments totaled $69.0 million as of June 30, an increase of $9.1 million from the prior quarter. The increase in cash includes the deferred payment of $5.1 million, Third Wave said.

 

Third Wave raised its product revenue guidance for 2004 from $39 million to $42 million.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.